| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9268596 | Journal of Clinical Virology | 2005 | 6 Pages |
Abstract
The amount of non-virus-inactivated clotting factor is not predictive for the risk of GBV-C/HGV infection in hemophiliacs. Despite repeated parenteral exposure more than 55% of hemophiliacs were not infected with GBV-C/HGV. Our findings indicate a high frequency of host factors preventing parenteral transmission of GBV-C/HGV.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Bernd Kupfer, Torsten Ruf, Bertfried Matz, Jacob Nattermann, Ulrich Spengler, Jürgen K. Rockstroh, Hans H. Brackmann, Johannes Blümel, Michael Tacke, Rolf Kaiser,